Project could yield new and better treatments for disease
Company signs licence for MelioVac, a pre-clinical vaccine for melioidosis
Company will use money from listing to meet costs for flu drug trials, develop assets
Opsona Therapeutics tests immune-dampening to ward of dangerous inflamation after transplants. Claire O’Connell finds out about the science behind it
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices